We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Volkswagen (VLKAY) to Recall 411K Polo and Seat Vehicles
Read MoreHide Full Article
Per Reuters, Volkswagen AG announced that it will recall roughly 220,000 units of new Polo vehicles due to defective rear seatbelt lock. Additionally, 191,000 cars of the company’s Spanish subsidiary Seat are also affected. The recall will begin in the coming weeks. The affected vehicles have a technical problem, which in unusual situations could release the rear left seatbelt.
The worldwide recall is restricted to regions where Seat and Polo cars are sold. The affected models under Seat include the 2018 models of Arona, and 2017 and 2018 models of Ibiza.
Almost at the same time, Volkswagen’s subsidiary Audi AG announced that will present a software upgrade to Germany's motor authority KBA for roughly 60,000 cars after detecting emission-related problems. Further, the auto manufacturer stopped selling its A6 and A7 models after finding a problem with emissions software for a specific type of diesel engine.
In March, the company announced roughly 4.86 million vehicle recall in China due to Takata-airbag problem. The recall was applicable to both imported and locally-manufactured vehicles.
These recalls are likely to add to the company’s expenses, which are already hit by penalties for the emission scandal of September 2015. Further, this is likely to reduce the already-dented consumer confidence in the brand.
Price Performance
In a month’s time, Volkswagen’s stock has declined 4.6%, underperforming 2.2% gain of the industry it belongs to.
Zacks Rank & Other Stocks to Consider
Volkswagen currently carries a Zacks Rank #2 (Buy). Other top-ranked stocks in the auto space are Fiat Chrysler Automobiles N.V. , Oshkosh Corporation (OSK - Free Report) and General Motors Corporation (GM - Free Report) . Fiat Chrysler and Oshkosh sport a Zacks Rank #1 (Strong Buy) while General Motors carries a Zacks Rank of 2. You can see the complete list of today’s Zacks #1 Rank stocks here.
Fiat Chrysler has expected long-term growth rate of 23.7%. In a year’s time, shares of the company have gained 103.7%.
Oshkosh has expected long-term growth rate of 18.3%. Shares of the company have risen 11.9% over the past year.
General Motors has expected long-term growth rate of 5.5%. Over the past year, shares of the company have gained 9%.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Image: Bigstock
Volkswagen (VLKAY) to Recall 411K Polo and Seat Vehicles
Per Reuters, Volkswagen AG announced that it will recall roughly 220,000 units of new Polo vehicles due to defective rear seatbelt lock. Additionally, 191,000 cars of the company’s Spanish subsidiary Seat are also affected. The recall will begin in the coming weeks. The affected vehicles have a technical problem, which in unusual situations could release the rear left seatbelt.
The worldwide recall is restricted to regions where Seat and Polo cars are sold. The affected models under Seat include the 2018 models of Arona, and 2017 and 2018 models of Ibiza.
Almost at the same time, Volkswagen’s subsidiary Audi AG announced that will present a software upgrade to Germany's motor authority KBA for roughly 60,000 cars after detecting emission-related problems. Further, the auto manufacturer stopped selling its A6 and A7 models after finding a problem with emissions software for a specific type of diesel engine.
Volkswagen AG Price and Consensus
Volkswagen AG Price and Consensus | Volkswagen AG Quote
In March, the company announced roughly 4.86 million vehicle recall in China due to Takata-airbag problem. The recall was applicable to both imported and locally-manufactured vehicles.
These recalls are likely to add to the company’s expenses, which are already hit by penalties for the emission scandal of September 2015. Further, this is likely to reduce the already-dented consumer confidence in the brand.
Price Performance
In a month’s time, Volkswagen’s stock has declined 4.6%, underperforming 2.2% gain of the industry it belongs to.
Zacks Rank & Other Stocks to Consider
Volkswagen currently carries a Zacks Rank #2 (Buy). Other top-ranked stocks in the auto space are Fiat Chrysler Automobiles N.V. , Oshkosh Corporation (OSK - Free Report) and General Motors Corporation (GM - Free Report) . Fiat Chrysler and Oshkosh sport a Zacks Rank #1 (Strong Buy) while General Motors carries a Zacks Rank of 2. You can see the complete list of today’s Zacks #1 Rank stocks here.
Fiat Chrysler has expected long-term growth rate of 23.7%. In a year’s time, shares of the company have gained 103.7%.
Oshkosh has expected long-term growth rate of 18.3%. Shares of the company have risen 11.9% over the past year.
General Motors has expected long-term growth rate of 5.5%. Over the past year, shares of the company have gained 9%.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>